New microfluidic device quickly and automatically predicts the effectiveness of cancer treatment

One of the great challenges in the fight against cancer is to design new technologies for a personalized treatment for each patient.

Related Keywords

Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Hebron ,Israel General ,Israel ,Javier Ram ,Emily Henderson ,Joan Montero ,Albert Manzano ,Anthony Letai ,Ub Department Of Biomedicine ,Hebron Institute Of Oncology ,Biomedical Research Networking Center ,Health Sciences Of The University Barcelona ,Institute For Bioengineering Of Catalonia ,Dana Farber Cancer Institute United States ,Cancer Research ,Cancer Research Industry ,Health Sciences ,Precision Oncology ,Hebron Institute ,Professor Anthony Letai ,Professor Montero ,Dana Farber Cancer Institute ,United States ,Research Industry Focus ,Science Signaling ,Cancer ,Cancer Therapy ,Microfluidics ,Essay ,Ioengineering ,Ebiomedicine ,Biopsy ,Cancer Treatment ,Na ,Nex Vivo ,Medicine ,Ncology ,Pathology ,Precision Medicine ,Research ,